These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Drug treatment for benign prostatic hyperplasia. Several trials have shown benefit of finasteride. Collins GN BMJ; 1997 Aug; 315(7104):371. PubMed ID: 9270474 [No Abstract] [Full Text] [Related]
6. Benign prostatic hyperplasia (BPH). Harv Mens Health Watch; 2006 Aug; 11(1):3. PubMed ID: 17111474 [No Abstract] [Full Text] [Related]
7. [Finasteride in prolonged therapy of patients with benign prostatic hyperplasia]. Mazo EB Urologiia; 2001; (3):20-2. PubMed ID: 11505535 [TBL] [Abstract][Full Text] [Related]
8. [Efficacy of finasteride in the treatment of hematuria associated with benign prostatic hypertrophy]. Palou Redorta J; Gausa Gascon L; Salvador Bayarre J; Millán Rodríguez F; Segarra Tomás J; Villavicencio Mavrich H Arch Esp Urol; 2002 Oct; 55(8):895-9. PubMed ID: 12455279 [TBL] [Abstract][Full Text] [Related]
9. Current management and future trends in benign prostatic hyperplasia (BPH). Fitzpatrick JM Ir Med J; 1997 Nov; 90(7):256, 258. PubMed ID: 10036815 [No Abstract] [Full Text] [Related]
10. Drug treatment for benign prostatic hyperplasia. To interpret PSA concentrations in patients taking finasteride, multiply them by two. Taneja S BMJ; 1997 Aug; 315(7104):371. PubMed ID: 9270475 [No Abstract] [Full Text] [Related]
11. [Therapy of benign prostatic hyperplasia with finasteride and doxazosin -- long-term studies support the combination]. Hausmann R; Thalmann G; Reich O; Steif CG Aktuelle Urol; 2004 Sep; 35(5):339-42. PubMed ID: 15383991 [No Abstract] [Full Text] [Related]
12. Finasteride for BPH. Johnson KH; Casey CM J Fam Pract; 1998 Jun; 46(6):455-6. PubMed ID: 9638104 [No Abstract] [Full Text] [Related]
13. [Long-term results of proscar (finasteride, MSD) treatment of patients with benign prostatic hyperplasia]. Tkachuk VN; Al'-Shukri SKh; Kornienko VI; Kuz'min IV Urol Nefrol (Mosk); 1998; (4):37-9. PubMed ID: 9727320 [TBL] [Abstract][Full Text] [Related]
14. Finasteride in benign prostatic hyperplasia. Verhamme KM; Bosch RJ; Sturkenboom MC N Engl J Med; 2004 Mar; 350(13):1359-61; author reply 1359-61. PubMed ID: 15049034 [No Abstract] [Full Text] [Related]
15. The impact of 5-alpha-reductase inhibitors on the number of prostatectomies for benign prostatic hyperplasia. Agha AH; Roy JB; Culkin DJ; Lyon K Adv Ther; 1995; 12(6):361-6. PubMed ID: 10163332 [TBL] [Abstract][Full Text] [Related]
16. Effects of 5 alpha-reductase inhibition by finasteride on lipoproteins and body composition in males affected by benign prostatic hyperplasia (BPH). Denti L; Pasolini G; Cortellini P; Sanfelici L; Benedetti R; Cecchetti A; Ferretti S; Banchini A; Ablondi F; Valenti G J Endocrinol Invest; 1999; 22(10 Suppl):70-1. PubMed ID: 10727053 [No Abstract] [Full Text] [Related]